{"id":13041,"date":"2025-07-02T09:59:48","date_gmt":"2025-07-02T13:59:48","guid":{"rendered":"https:\/\/clariowebstg.wpengine.com\/?post_type=solutions&#038;p=13041"},"modified":"2025-08-13T12:05:00","modified_gmt":"2025-08-13T16:05:00","slug":"phase-1-clinical-trial-solutions","status":"publish","type":"solutions","link":"https:\/\/clario.com\/solutions\/phase-1-clinical-trial-solutions\/","title":{"rendered":"Phase I Clinical Trial Solutions"},"content":{"rendered":"<div class=\"clario-section light-grey-50\">\n  <div class=\"container\">\n      \n\n<h2 class=\"wp-block-heading has-text-align-center\" id=\"h-phase-i-experience-data\">Phase I experience data<\/h2>\n\n\n<div class=\"clario-statistics-display row justify-content-center\"><div class=\"col-6 col-md-4 col-lg-4 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"Trial Supply Management Icon Reverse RGB\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2023\/05\/Trial-Supply-Management-Icon-Reverse-RGB.svg\" height=\"auto\" width=\"auto\"><p class=\"stat\">7,400+<\/p><p class=\"stat-text\">clinical trials supported<\/p><\/div><div class=\"col-6 col-md-4 col-lg-4 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"Site Icon Reverse RGB\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2023\/05\/Site-Icon-Reverse-RGB.svg\" height=\"auto\" width=\"auto\"><p class=\"stat\">92,000+<\/p><p class=\"stat-text\">trial sites enabled<\/p><\/div><div class=\"col-6 col-md-4 col-lg-4 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"Team Icon Reverse RGB\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2023\/05\/Team-Icon-Reverse-RGB.svg\" height=\"auto\" width=\"auto\"><p class=\"stat\">1,350,000+<\/p><p class=\"stat-text\">participants engaged<\/p><\/div><\/div>\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section pb-0\">\n  <div class=\"container\">\n      \n<div class=\"row\">\n\t\n\n<div class=\"col-12 col-md-9\">\n\t\t\t\n\n<h2 class=\"wp-block-heading\" id=\"h-safety-is-priority-1-in-early-phase-studies\">Safety is priority #1 in early phase studies<\/h2>\n\n\n\n<p>Safety is the foundation of every early-phase study, guiding critical decisions that shape the future of your drug\u2019s development. Rigorous monitoring and regulatory compliance help identify potential risks early, ensuring patient well-being while generating the meaningful data needed for confidence in next steps. With the right expertise, you can navigate safety requirements efficiently &#8211; accelerating your path to later-phase success.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading mb-0\" id=\"h-clario-supports-your-safety-studies-in-multiple-ways\">Clario supports your safety studies in multiple ways:<\/h3>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section\">\n  <div class=\"container\">\n      \n<div class=\"row align-items-center\">\n\t\n\n<div class=\"col-12 col-md-6 mb-2 mb-md-0\">\n\t\t\t\n\n<div class=\"clario-video-lightbox \">\n    <button class=\"no-button wp-embed-aspect-16-9 wp-has-aspect-ratio\" data-toggle=\"modal\" data-target=\"#video-lightbox-05fd40ef\" tabindex=\"0\" aria-label=\"Watch video\">\n        <img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"450\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/01\/Leveraging-Early-stage-Safety-Methodologies-and-AI-to-Maximize-Your-Opportunity-for-a-TQT-Waiver-800x450.png\" class=\"img-fluid\" alt=\"Leveraging Early stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver\" \/>    <\/button>\n<\/div>\n\n<div class=\"clario-video-lightbox-modal modal no-frame fade\" id=\"video-lightbox-05fd40ef\" tabindex=\"-1\" role=\"dialog\" aria-hidden=\"true\">\n    <div class=\"modal-dialog modal-dialog-centered modal-xl\" role=\"document\">\n        <div class=\"modal-content\">\n            <div class=\"modal-body\">\n                <div class=\"video-player\" itemprop=\"video\" itemscope itemtype=\"http:\/\/schema.org\/VideoObject\"><iframe loading=\"lazy\" title=\"Leveraging Early stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/XASOkQaL-U8?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><meta itemprop=\"name\" content=\"Video\" \/><meta itemprop=\"description\" content=\"Event video\" \/><meta itemprop=\"thumbnailUrl\" content=\"https:\/\/clario.com\/wp-content\/themes\/understrap\/assets\/default-thumb.jpg\" \/><meta itemprop=\"uploadDate\" content=\"2025-12-04T06:26:53+00:00\" \/><meta itemprop=\"embedUrl\" content=\"https:\/\/youtu.be\/XASOkQaL-U8?si=GDyv_jLXItxQoo9i\" \/><\/div>            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<script type=\"text\/javascript\">\n    jQuery(window).on(\"load\", function() {\n        Clario.VideoLightbox.configure('#video-lightbox-05fd40ef', false); \/\/ Escape JS output\n    });\n<\/script>\n\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n\n<h3 class=\"wp-block-heading\" id=\"h-cardiac-safety-monitoring\">Cardiac safety monitoring<\/h3>\n\n\n\n<p>All drugs enter the bloodstream and circulate through the heart, which introduces the possibility of cardiac adverse effects. Evaluating ECGs for prolongation of the QT interval is essential because it is; a critical risk for detection in early development. <\/p>\n\n\n\n<p>Clario\u2019s Early Precision QT\u00ae (EPQT) methodology delivers highly precise ECG data to detect the smallest change and can help support a potential waiver for a future dedicated Thorough QT (TQT) studies.<\/p>\n\n\n\n<div class=\"wp-block-buttons mt-2 is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary\" data-target=\"#video-lightbox-05fd40ef\" data-toggle=\"modal\"><a class=\"wp-block-button__link wp-element-button\">Hear our experts discuss the value of EPQT<\/a><\/div>\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section pt-0\">\n  <div class=\"container\">\n      \n<div class=\"row justify-content-center align-items-center\">\n\t\n\n<div class=\"col-12 col-sm-12 col-md-5 order-1 order-md-2\">\n\t\t\t\n  <div class=\"clario-collection clario-collection-select row  clario-collection-count-1\">\n                              <article class=\"mb-2 col-12 col-md-6 col-xl-12\">\n              <a href=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/06\/DataSheet-CS-Certified-Sites.pdf\" target=\"_blank\" class=\"clario-thumb-resource clario-thumb clario-thumb-type-resource clario-thumb-type-post dark-purple\">\n    <span class=\"clario-thumb-category label\">Datasheet<\/span>\n    <h4 class=\"clario-thumb-title\">Clario certified sites<\/h4>\n    <div class=\"clario-thumb-row row\">\n      <div class=\"col-6 clario-thumb-icon\">\n        <img loading=\"lazy\" decoding=\"async\" width=\"36\" height=\"36\" class=\"clario-thumb-mian-image clario-thumb-rs-icon\" alt=\"Download icon\" src=\"https:\/\/clario.com\/wp-content\/themes\/clario-bootstrap\/media\/icons\/resource-download-icon-white.svg\">\n        <img loading=\"lazy\" decoding=\"async\" width=\"36\" height=\"36\" class=\"clario-thumb-hover-image clario-thumb-rs-icon\" alt=\"Download icon\" src=\"https:\/\/clario.com\/wp-content\/themes\/clario-bootstrap\/media\/icons\/resource-download-icon-white.svg\">\n      <\/div>\n      <div class=\"col-6 clario-thumb-link-text\"><span class=\"clario-thumb-link button primary\">Download<\/span><\/div>\n    <\/div>\n  <\/a>\n          <\/article>\n                          <\/div>\n\n\t<\/div>\n\n\n\n<div class=\"col-12 col-sm-12 col-md-6 col-lg-7 order-2 order-md-1\">\n\t\t\t\n\n<h3 class=\"wp-block-heading\" id=\"h-phase-i-certified-sites\">Phase I certified sites<\/h3>\n\n\n\n<p>We work with a network of pre-screened, highly trained Phase I sites across the globe to collect reproducible, high-quality digital ECG data. These sites are continually evaluated to ensure they meet data quality standards. <\/p>\n\n\n\n<p>Additionally, by working with well-trained and well-equipped sites, you will increase the potential to reduce study start-up time.&nbsp;<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/clario.com\/datasheet-cs-certified-sites\/\" target=\"_blank\" rel=\"noreferrer noopener\">Read about our certified site program<\/a><\/div>\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section pt-0\">\n  <div class=\"container\">\n      \n<div class=\"row\">\n\t\n\n<div class=\"col-12 col-md-6\">\n\t\t\t<div class=\"h-100 d-flex flex-column justify-content-center\">\n\t\t\t\n<div class=\"responsive-image-block\">\n    <div class=\"row justify-content-between align-items-center\">\n        <div class=\"col-12 mb-2 responsive-image\">\n            <div class=\"img-container img-container-desktop\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/06\/5-reasons-listicle-pixel-image.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"5-reasons-listicle-pixel-image\">\n                            <\/div>\n            <div class=\"img-container img-container-mobile\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/06\/5-reasons-listicle-pixel-image.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"5-reasons-listicle-pixel-image\">\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t\t<\/div>\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6\">\n\t\t\t<div class=\"h-100 d-flex flex-column justify-content-center\">\n\t\t\t\n\n<h3 class=\"wp-block-heading\" id=\"h-regulatory-and-study-design-consulting\">Regulatory and study design consulting<\/h3>\n\n\n\n<p>Even as you\u2019re designing your pre-clinical studies, our team of experts can support your development strategy to transition into early phase clinical studies and beyond. <\/p>\n\n\n\n<p>With a legacy of engaging with regulatory bodies to establish standards and guidance, Clario is uniquely capable of guiding you through the complex regulatory landscape and optimizing your studies for maximum impact.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary is-style-cta-1\" data-=\"\"><a class=\"wp-block-button__link wp-element-button\" href=\"#popup-1\">Talk with our scientists<\/a><\/div>\n<\/div>\n\n\t\t<\/div>\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section clario-cta clario-cta-layout-standard  light-grey-50 show-bg-pixel \">\n  <div class=\"container\">\n    <div class=\"row align-items-md-center\">\n        <div class=\"clario-cta-content col-md-6 offset-md-1 col-10\"><p class=\"h2\">Meet your E14 regulatory requirements early with EPQT<\/p><p><p>Small molecule compounds in development must undergo rigorous ECG testing for their potential to prolong the QT interval as defined in the ICH E14 Guidance. Our team can help you meet these requirements earlier and potentially save millions by avoiding a dedicated TQT study later in development.<\/p>\n<\/p><\/div><div class=\"cta-buttons offset-md-1 col-md-4 col-10\"><div class=\"clario-second-cta-action\"><a href=\"https:\/\/clario.com\/meet-your-e14-regulatory-requirements-early-with-epqt\/\" class=\"second-cta-action \">Learn how it works<\/a><\/div><\/div>    <\/div>\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section\">\n  <div class=\"container\">\n      \n<div class=\"row\">\n\t\n\n<div class=\"col-12 col-md-12\">\n\t\t\t\n<div class=\"row\">\n\t\n\n<div class=\"col-12 col-md-9\">\n\t\t\t\n\n<h2 class=\"wp-block-heading\" id=\"h-go-beyond-safety-and-get-early-signals-on-your-drug-s-potential-benefits\">Go beyond safety and get early signals on your drug&#8217;s potential benefits<\/h2>\n\n\n\n<p>Early-phase studies provide an opportunity to have a first look at the impacts your drug may provide. While these studies may have fewer patients enrolled, you can obtain preliminary insights to inform what endpoints may be valuable to pursue in later phase studies, and help with pipeline prioritization.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-clario-offers-accessible-early-phase-efficacy-and-quality-of-life-solutions-with-quick-study-starts-including-nbsp\">Clario offers accessible early phase efficacy and quality of life solutions with quick study starts, including:&nbsp;<\/h3>\n\n\t<\/div>\n\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section py-0 mt-0 \">\n  <div class=\"container\">\n      \n<div class=\"row mb-3 align-items-center\">\n\t\n\n<div class=\"col-12 col-md-6 order-md-2\">\n\t\t\t\n<div class=\"responsive-image-block\">\n    <div class=\"row justify-content-between align-items-center\">\n        <div class=\"col-12 mb-2 responsive-image\">\n            <div class=\"img-container img-container-desktop\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/06\/phase-1-rapid-start.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"\">\n                            <\/div>\n            <div class=\"img-container img-container-mobile\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/06\/phase-1-rapid-start.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"\">\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n\n<h3 class=\"wp-block-heading\" id=\"h-ecoa-clinical-trial-solutions\">eCOA clinical trial solutions<\/h3>\n\n\n\n<p><strong>Early phase trials demand speed and precision<\/strong>, especially when collecting patient-reported outcomes. Clario eCOA offers <a href=\"\/solutions\/ecoa\/ecoa-rapid-start\/\">rapid deployment, with pre-built, validated assessments<\/a> that streamline study set up. This ensures high-quality data collection to support early insights into efficacy and tolerability.&nbsp;<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary\"><a class=\"wp-block-button__link wp-element-button\" href=\"\/solutions\/ecoa\/ecoa-rapid-start\/\">Learn more about eCOA Rapid Start<\/a><\/div>\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section py-0 mt-0 \">\n  <div class=\"container\">\n      \n<div class=\"row mb-3 align-items-center\">\n\t\n\n<div class=\"col-12 col-md-6 order-md-1\">\n\t\t\t\n<div class=\"responsive-image-block\">\n    <div class=\"row justify-content-between align-items-center\">\n        <div class=\"col-12 mb-2 responsive-image\">\n            <div class=\"img-container img-container-desktop\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/06\/phase-1-respiratory.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"\">\n                            <\/div>\n            <div class=\"img-container img-container-mobile\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/06\/phase-1-respiratory.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"\">\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6 order-md-2\">\n\t\t\t\n\n<h3 class=\"wp-block-heading\" id=\"h-respiratory-solutions\">Respiratory solutions<\/h3>\n\n\n\n<p>It can be challenging to obtain reliable lung function data in any study, but with a smaller patient population, it\u2019s even more critical to collect high quality data to understand the potential benefits and side effects.<\/p>\n\n\n\n<p>In addition to offering multiple modalities for lung function testing, we also provide training to site-based technicians to improve the quality of data collected.&nbsp;&nbsp;<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary\"><a class=\"wp-block-button__link wp-element-button\" href=\"\/solutions\/ecoa\/ecoa-rapid-start\/\">Explore our respiratory endpoint solutions<\/a><\/div>\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section py-0 mt-0\">\n  <div class=\"container\">\n      \n<div class=\"row mb-3 align-items-center\">\n\t\n\n<div class=\"col-12 col-md-6 order-md-2\">\n\t\t\t\n<div class=\"responsive-image-block\">\n    <div class=\"row justify-content-between align-items-center\">\n        <div class=\"col-12 mb-2 responsive-image\">\n            <div class=\"img-container img-container-desktop\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2023\/05\/respiratory-image-3a-600x600.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"respiratory-image-3a\">\n                            <\/div>\n            <div class=\"img-container img-container-mobile\">\n                                    <img decoding=\"async\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2023\/05\/respiratory-image-3a-600x600.png\" class=\"default-pixel img-fluid\" height=\"auto\" width=\"auto\" alt=\"respiratory-image-3a\">\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n\n<h3 class=\"wp-block-heading\" id=\"h-medical-imaging-solutions\">Medical imaging solutions<\/h3>\n\n\n\n<p>Medical imaging in early phase trials delivers early proof of efficacy and quality of life impact through high-value modalities like MRI, PET, and CT. These tools provide clear, objective data even in small populations, helping you detect biological activity, track disease progression, and assess organ response. <\/p>\n\n\n\n<p><strong>The result:<\/strong> faster, more confident decisions, smarter endpoint selection, and reduced risk and cost in later phases.<\/p>\n\n\n\n<p>See how Clario\u2019s imaging solutions can accelerate your early phase decisions.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary\"><a class=\"wp-block-button__link wp-element-button\" href=\"\/solutions\/ecoa\/ecoa-rapid-start\/\">Learn more<\/a><\/div>\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section light-grey-50\">\n  <div class=\"container\">\n      \n\n<h2 class=\"wp-block-heading\" id=\"h-related-resources\">Related resources<\/h2>\n\n\n  <div class=\"clario-collection clario-collection-select row  clario-collection-count-2\">\n                              <article class=\"mb-2 col-12 col-md-6 col-xl-4\">\n                <a href=\"https:\/\/clario.com\/resources\/webinars\/innovation-in-qt-strategies-leveraging-early-stage-safety-methodologies-and-ai-to-maximize-your-opportunity-for-a-tqt-waiver-webinar-replay\/\" class=\"clario-thumb-resource clario-thumb clario-thumb-type-resource clario-thumb-type-post dark-purple\">\n        <span class=\"clario-thumb-category label\">Webinar<\/span>\n        <h4 class=\"clario-thumb-title\">Innovation in QT Strategies: Leveraging Early-stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver Webinar Replay<\/h4>\n        <div class=\"clario-thumb-row row\">\n            <div class=\"col-6 clario-thumb-icon\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"36\" height=\"36\" class=\"clario-thumb-mian-image clario-thumb-rs-icon\" alt=\"Watch icon\" src=\"https:\/\/clario.com\/wp-content\/themes\/clario-bootstrap\/media\/icons\/resource-watch-icon-white.svg\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"36\" height=\"36\" class=\"clario-thumb-hover-image clario-thumb-rs-icon\" alt=\"Watch icon\" src=\"https:\/\/clario.com\/wp-content\/themes\/clario-bootstrap\/media\/icons\/resource-watch-icon-white.svg\">\n            <\/div>\n            <div class=\"col-6 clario-thumb-link-text\"><span class=\"clario-thumb-link button primary\">Watch<\/span><\/div>\n        <\/div>\n    <\/a>\n          <\/article>\n                  <article class=\"mb-2 col-12 col-md-6 col-xl-4\">\n              <a href=\"https:\/\/clario.com\/wp-content\/uploads\/2025\/01\/WhitePaper_CS_TheEPQTApproach_15Jan2025.pdf\" target=\"_blank\" class=\"clario-thumb-resource clario-thumb clario-thumb-type-resource clario-thumb-type-post dark-purple\">\n    <span class=\"clario-thumb-category label\">White Paper<\/span>\n    <h4 class=\"clario-thumb-title\">The early precision QT approach<\/h4>\n    <div class=\"clario-thumb-row row\">\n      <div class=\"col-6 clario-thumb-icon\">\n        <img loading=\"lazy\" decoding=\"async\" width=\"36\" height=\"36\" class=\"clario-thumb-mian-image clario-thumb-rs-icon\" alt=\"Download icon\" src=\"https:\/\/clario.com\/wp-content\/themes\/clario-bootstrap\/media\/icons\/resource-download-icon-white.svg\">\n        <img loading=\"lazy\" decoding=\"async\" width=\"36\" height=\"36\" class=\"clario-thumb-hover-image clario-thumb-rs-icon\" alt=\"Download icon\" src=\"https:\/\/clario.com\/wp-content\/themes\/clario-bootstrap\/media\/icons\/resource-download-icon-white.svg\">\n      <\/div>\n      <div class=\"col-6 clario-thumb-link-text\"><span class=\"clario-thumb-link button primary\">Download<\/span><\/div>\n    <\/div>\n  <\/a>\n          <\/article>\n                          <\/div>\n\n  <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p> [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/clario.com\/solutions\/phase-1-clinical-trial-solutions\/\">Read More&#8230;<span class=\"screen-reader-text\"> from Phase I Clinical Trial Solutions<\/span><\/a><\/p>\n","protected":false},"featured_media":2633,"parent":0,"menu_order":0,"template":"","tags":[],"class_list":["post-13041","solutions","type-solutions","status-publish","has-post-thumbnail","hentry"],"acf":[],"cp_meta_data":{"_edit_lock":["1755189671:7"],"_edit_last":["7"],"display_prefooter":["hide"],"_display_prefooter":["field_61641783f0f7c"],"page_title":[""],"_page_title":["field_615dbd9cfca50"],"select_hero_section_type":["video"],"_select_hero_section_type":["field_63e9c1ac237af"],"hero_section_video_url":["<iframe width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/nMeYEOzOSjU?si=BokPwpH40kxZwjtq\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>"],"_hero_section_video_url":["field_63e9c219237b0"],"introduction":["Maximize confidence in your next-phase drug development decisions with <strong>high quality, informative early-phase data<\/strong>."],"_introduction":["field_614c581e34348"],"introduction_paragraph":["Navigate the complexities of first-in-human (FIH) and early-phase studies with expert support. From pursuing waivers for additional safety studies later in development, to prioritizing your pipeline, we help you make informed, strategic decisions based on reliable, high-quality early phase data."],"_introduction_paragraph":["field_629ee2f209b6b"],"call_to_action_button":["1"],"_call_to_action_button":["field_629888a6435a9"],"cta_btn_text":["Get started"],"_cta_btn_text":["field_62984e409758b"],"cta_btn_url":["#popup-1"],"_cta_btn_url":["field_62984e699758c"],"cta_url_open_new_tab":["0"],"_cta_url_open_new_tab":["field_629dce361d7e6"],"cta_btn_css_class":[""],"_cta_btn_css_class":["field_62bab8d5adfa4"],"cta_btn_style":["cta-1"],"_cta_btn_style":["field_62986b9c7c2ee"],"persistent_cta":["hide"],"_persistent_cta":["field_6375dc7c0b25c"],"show_popup":["1"],"_show_popup":["field_62b1aec56dcb5"],"solutions":[""],"_solutions":["field_61eac16edee33"],"solutions_category":[""],"_solutions_category":["field_61eac09d5e59c"],"therapeutic_areas":[""],"_therapeutic_areas":["field_61eac19284449"],"_ame_cpe_post_policy":["{\"accessProtection\":{\"active\":\"replace\"}}"],"_yoast_wpseo_content_score":["90"],"_yoast_wpseo_focuskeywords":[""],"_yoast_wpseo_keywordsynonyms":[""],"_yoast_wpseo_estimated-reading-time-minutes":["3"],"popup_box_id":["popup-1"],"_popup_box_id":["field_62b1ab70ff7f5"],"_yoast_indexnow_last_ping":["1755101100"],"_thumbnail_id":["2633"]},"_links":{"self":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/solutions\/13041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/solutions"}],"about":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/types\/solutions"}],"version-history":[{"count":0,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/solutions\/13041\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/media\/2633"}],"wp:attachment":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/media?parent=13041"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/tags?post=13041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}